Indian healthcare sector faces escalating cyber risks as complex hospital IT systems widen attack surface: Nandita Vijayasimha, Bengaluru Wednesday, April 22, 2026, 08:00 Hrs [IST ...
Rising liver disorders driving demand for hepatoprotective drugs in India: Dr Sameer Bhati: Shardul Nautiyal, Mumbai Wednesday, April 22, 2026, 08:00 Hrs [IST] The rising incidenc ...
The new recommendation by the DTAB is in deviation from the earlier proposal that the qualification of the competent person should be with pharmacy background only i.e. D. Pharmacy/B. Pharmacy/M.
The Department of Drugs Control in Pondicherry is set to commission its newly upgraded, sophisticated drug testing laboratory (DTL) next month, marking a major milestone in the Union Territory’s ...
The Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DoP) to consistently monitor the progress of the medical devices parks in coordination with ...
MedTech startup MediElaj aims expansion of AI-based healthcare model: Our Bureau, New Delhi Wednesday, April 22, 2026, 08:00 Hrs [IST] MedTech startup MediElaj is planning to roll ...
Rusan Pharma achieves global GMP milestone with PMDA Japan approval: Our Bureau, Mumbai Tuesday, April 21, 2026, 17:15 Hrs [IST] Rusan Pharma, a leading pharmaceutical company pio ...
Jeena Sikho Lifecare & Sat Kartar Life ink collaboration to build a technology-enabled Ayurveda healthcare ecosystem: Our Bureau, Mumbai Tuesday, April 21, 2026, 13:45 Hrs [IST] I ...
US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility: Tokyo Tuesday, April 2 ...
Ampersand Biomedicines presents preclinical data on AMP-220, a gut-targeted IL-22 AND-Body therapeutic, at AAI 2026: Boston Tuesday, April 21, 2026, 17:00 Hrs [IST] Ampersand Biom ...
Medprime solves manual pathology bottlenecks with the launch of Cilika AI for faster, scalable diagnostics: Our Bureau, Bengaluru Tuesday, April 21, 2026, 17:30 Hrs [IST] Medprime ...
Specialised Therapeutics receives approval from Australia & Singapore for Zepzelca in combo with atezolizumab for advanced small cell lung cancer: Singapore Tuesday, April 21, 202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results